Pharma

The addition of Truqap to standard-of-care therapy improved radiographic progression-free survival in patients with metastatic prostate cancer and loss of...

1. In this target trial emulation study, denosumab was associated with an increased risk of major adverse cardiovascular events compared...

The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients with relapsed/refractory...

1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults...

1. In this retrospective cohort study, gabapentin use was associated with a reduced incidence of fall-related healthcare visits in older...

Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The novel therapy was safe and...

1. Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo....

Adult clinical trials found that Tremfya could treat plaque psoriasis by 16 weeks. Follow-up analysis found that roughly 23% of...

1. In this prospective cohort study, genetic screening among Australian reproductive couples was widely accepted and associated with low decisional...

1. Tranexamic acid significantly reduced life-threatening postpartum bleeding. 2. There were no differences in the risk of thromboembolic events. Evidence...